BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giuliano CA, Patel CR, Kale-pradhan PB. Is the Combination of Piperacillin-Tazobactam and Vancomycin Associated with Development of Acute Kidney Injury? A Meta-analysis. Pharmacotherapy 2016;36:1217-28. [DOI: 10.1002/phar.1851] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Triffault-Fillit C, Mabrut E, Corbin K, Braun E, Becker A, Goutelle S, Chaudier P, Fessy MH, Dupieux C, Laurent F, Gunst S, Lustig S, Chidiac C, Ferry T, Valour F. Tolerance and microbiological efficacy of cefepime or piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of prosthetic joint infection: a propensity-matched cohort study. J Antimicrob Chemother 2020;75:2299-306. [PMID: 32407512 DOI: 10.1093/jac/dkaa166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Molina KC, Barletta JF, Hall ST, Yazdani C, Huang V. The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin-Tazobactam or Cefepime. J Intensive Care Med 2020;35:1434-8. [PMID: 30741072 DOI: 10.1177/0885066619828290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
3 Watkins RR, Deresinski S. Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy—What Is the Clinician to Do? Clinical Infectious Diseases 2017;65:2137-43. [DOI: 10.1093/cid/cix675] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
4 Kalligeros M, Karageorgos SA, Shehadeh F, Zacharioudakis IM, Mylonakis E. The association of acute kidney injury with the concomitant use of vancomycin and piperacillin/tazobactam in children: A systematic review and meta-analysis. Antimicrob Agents Chemother 2019:AAC. [PMID: 31591125 DOI: 10.1128/AAC.01572-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Casapao AM, Jacobs DM, Bowers DR, Beyda ND, Dilworth TJ; the REACH-ID Study Group. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis. Pharmacotherapy 2017;37:1347-56. [DOI: 10.1002/phar.2034] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
6 Awdishu L. Drug-induced kidney disease in the ICU: mechanisms, susceptibility, diagnosis and management strategies. Curr Opin Crit Care 2017;23:484-90. [PMID: 28953558 DOI: 10.1097/MCC.0000000000000453] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Rutter WC, Hall RG, Burgess DS. Impact of total body weight on rate of acute kidney injury in patients treated with piperacillin-tazobactam and vancomycin. Am J Health Syst Pharm 2019;76:1211-7. [PMID: 31369116 DOI: 10.1093/ajhp/zxz120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Le P, Navaneethan SD, Yu PC, Pallotta AM, Rastogi R, Patel P, Brateanu A, Imrey PB, Rothberg MB. Association of antibiotic use and acute kidney injury in patients hospitalized with community-acquired pneumonia. Curr Med Res Opin 2021;:1-8. [PMID: 34714213 DOI: 10.1080/03007995.2021.2000716] [Reference Citation Analysis]
9 Buhlinger KM, Fuller KA, Faircloth CB, Wallace JR. Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients. Am J Health Syst Pharm 2019;76:1204-10. [PMID: 31369115 DOI: 10.1093/ajhp/zxz125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Luther MK, Timbrook TT, Caffrey AR, Dosa D, Lodise TP, LaPlante KL. Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis. Crit Care Med 2018;46:12-20. [PMID: 29088001 DOI: 10.1097/CCM.0000000000002769] [Cited by in Crossref: 96] [Cited by in F6Publishing: 40] [Article Influence: 19.2] [Reference Citation Analysis]
11 Yabes JM, Stewart L, Shaikh F, Robben PM, Petfield JL, Ganesan A, Campbell WR, Tribble DR, Blyth DM. Risk of Acute Kidney Injury in Combat-Injured Patients Associated With Concomitant Vancomycin and Extended-Spectrum β-Lactam Antibiotic Use. J Intensive Care Med 2021;36:818-27. [PMID: 32508215 DOI: 10.1177/0885066620930994] [Reference Citation Analysis]
12 Mullins BP, Kramer CJ, Bartel BJ, Catlin JS, Gilder RE. Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study. Ann Pharmacother 2018;52:639-44. [DOI: 10.1177/1060028018757497] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
13 Saito S, Sugimoto T, Takenaka K, Goto H, Kumahara A, Watanabe R, Sugiyama D, Yasutomo Y, Takatsuki K. The association of high Vancomycin trough concentration with acute kidney injury during combination therapy of Piperacillin/Tazobactam and Vancomycin. Practical Laboratory Medicine 2022;29:e00266. [DOI: 10.1016/j.plabm.2022.e00266] [Reference Citation Analysis]
14 Chen X, Xu R, Zhou X, Liu Y, Hu C, Xie X. Acute kidney injury associated with concomitant vancomycin and piperacillin/tazobactam administration: a systematic review and meta-analysis. Int Urol Nephrol 2018;50:2019-26. [DOI: 10.1007/s11255-018-1870-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
15 Filippone EJ, Kraft WK, Farber JL. The Nephrotoxicity of Vancomycin. Clin Pharmacol Ther 2017;102:459-69. [PMID: 28474732 DOI: 10.1002/cpt.726] [Cited by in Crossref: 108] [Cited by in F6Publishing: 95] [Article Influence: 21.6] [Reference Citation Analysis]
16 Balcı C, Uzun Ö, Arıcı M, Hayran SA, Yüce D, Ünal S. Nephrotoxicity of piperacillin/tazobactam combined with vancomycin: should it be a concern? Int J Antimicrob Agents 2018;52:180-4. [PMID: 29649586 DOI: 10.1016/j.ijantimicag.2018.03.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
17 Carreno J, Smiraglia T, Hunter C, Tobin E, Lomaestro B. Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy. Int J Antimicrob Agents 2018;52:643-50. [PMID: 30103003 DOI: 10.1016/j.ijantimicag.2018.08.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
18 Joyce EL, Kane-Gill SL, Priyanka P, Fuhrman DY, Kellum JA. Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children. J Am Soc Nephrol 2019;30:2243-51. [PMID: 31501354 DOI: 10.1681/ASN.2018121223] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Alshehri AM, Alzahrani MY, Abujamal MA, Abdalla MH, Alowais SA, Alfayez OM, Alyami MS, Almutairi AR, Almohammed OA. Comparative Risk of Acute Kidney Injury Following Concurrent Administration of Vancomycin with Piperacillin/Tazobactam or Meropenem: A Systematic Review and Meta-Analysis of Observational Studies. Antibiotics 2022;11:526. [DOI: 10.3390/antibiotics11040526] [Reference Citation Analysis]
20 Mousavi M, Zapolskaya T, Scipione MR, Louie E, Papadopoulos J, Dubrovskaya Y. Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion. Pharmacotherapy 2017;37:379-85. [PMID: 28079263 DOI: 10.1002/phar.1901] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
21 Schreier DJ, Kashani KB, Sakhuja A, Mara KC, Tootooni MS, Personett HA, Nelson S, Rule AD, Steckelberg JM, Tande AJ, Barreto EF. Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin. Clin Infect Dis 2019;68:1456-62. [PMID: 30165426 DOI: 10.1093/cid/ciy724] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 14.5] [Reference Citation Analysis]
22 Lee JD, Heintz BH, Mosher HJ, Livorsi DJ, Egge JA, Lund BC. Risk of acute kidney injury and Clostridioides difficile infection with piperacillin/tazobactam, cefepime and meropenem with or without vancomycin. Clin Infect Dis 2020:ciaa1902. [PMID: 33382398 DOI: 10.1093/cid/ciaa1902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Finch NA, Zasowski EJ, Murray KP, Mynatt RP, Zhao JJ, Yost R, Pogue JM, Rybak MJ. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity. Antimicrob Agents Chemother 2017;61:e01293-17. [PMID: 28923869 DOI: 10.1128/AAC.01293-17] [Cited by in Crossref: 94] [Cited by in F6Publishing: 28] [Article Influence: 18.8] [Reference Citation Analysis]
24 Martin-Loeches I, Nunnally ME, Hellman J, Lat I, Martin GS, Jog S, Kesecioglu J, De Backer D, Coopersmith CM. Surviving Sepsis Campaign: Research Opportunities for Infection and Blood Purification Therapies. Crit Care Explor 2021;3:e0511. [PMID: 34514420 DOI: 10.1097/CCE.0000000000000511] [Reference Citation Analysis]
25 Aslan AT, Pashayev T, Dağ O, Akova M. Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury. Eur J Clin Microbiol Infect Dis 2021;40:1953-61. [PMID: 33884515 DOI: 10.1007/s10096-021-04258-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Hosohata K, Inada A, Oyama S, Furushima D, Yamada H, Iwanaga K. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach. J Clin Pharm Ther 2019;44:49-53. [DOI: 10.1111/jcpt.12748] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
27 Porter SA. Supratherapeutic Vancomycin Concentrations Associated With Hypothermia in a Burn Patient. J Burn Care Res 2018;39:1058-63. [PMID: 29931313 DOI: 10.1093/jbcr/irx038] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Robertson AD, Li C, Hammond DA, Dickey TA. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin‐Tazobactam or Meropenem. Pharmacotherapy 2018;38:1184-93. [DOI: 10.1002/phar.2179] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
29 Avedissian SN, Pais GM, Liu J, Rhodes NJ, Scheetz MH. Piperacillin-Tazobactam Added to Vancomycin Increases Risk for Acute Kidney Injury: Fact or Fiction? Clinical Infectious Diseases 2020;71:426-32. [DOI: 10.1093/cid/ciz1189] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
30 Triffault-Fillit C, Ferry T, Laurent F, Pradat P, Dupieux C, Conrad A, Becker A, Lustig S, Fessy MH, Chidiac C, Valour F; Lyon BJI Study Group. Microbiologic epidemiology depending on time to occurrence of prosthetic joint infection: a prospective cohort study. Clin Microbiol Infect 2019;25:353-8. [PMID: 29803842 DOI: 10.1016/j.cmi.2018.04.035] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
31 Clemmons AB, Bech CF, Pantin J, Ahmad I. Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime. Biology of Blood and Marrow Transplantation 2018;24:820-6. [DOI: 10.1016/j.bbmt.2017.12.799] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
32 Haruki Y, Hagiya H, Haruki M, Inoue Y, Sugiyama T. Concomitant vancomycin and piperacillin/tazobactam treatment is associated with an increased risk of acute kidney injury in Japanese patients. Journal of Infection and Chemotherapy 2020;26:1026-32. [DOI: 10.1016/j.jiac.2020.05.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Kimball JM, Deri CR, Nesbitt WJ, Nelson GE, Staub MB. Development of the Three Antimicrobial Stewardship E's (TASE) framework and Association between Stewardship Interventions and intended Results (ASIR) analysis to identify key facility-specific interventions and strategies for successful antimicrobial stewardship. Clin Infect Dis 2021:ciab430. [PMID: 33983389 DOI: 10.1093/cid/ciab430] [Reference Citation Analysis]
34 Blevins AM, Lashinsky JN, McCammon C, Kollef M, Micek S, Juang P. Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem. Antimicrob Agents Chemother 2019;63:e02658-18. [PMID: 30782987 DOI: 10.1128/AAC.02658-18] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 8.7] [Reference Citation Analysis]
35 Sharma R, Hammerschlag MR. Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Children: a Reappraisal of Vancomycin. Curr Infect Dis Rep 2019;21:37. [PMID: 31486979 DOI: 10.1007/s11908-019-0695-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
36 Holsen MR, Meaney CJ, Hassinger AB, Fusco NM. Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam. Pediatr Crit Care Med 2017;18:e585-91. [PMID: 28906422 DOI: 10.1097/PCC.0000000000001335] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
37 Al-Jebawi Y, Karalic K, Shekhawat P, Mhanna MJ. The concomitant use of vancomycin and piperacillin-tazobactam is associated with acute kidney injury (AKI) in extremely low birth weight infants (ELBW). J Neonatal Perinatal Med 2021. [PMID: 34864693 DOI: 10.3233/NPM-210866] [Reference Citation Analysis]
38 Triffault-Fillit C, Valour F, Guillo R, Tod M, Goutelle S, Lustig S, Fessy MH, Chidiac C, Ferry T; Lyon BJI Study Group. Prospective Cohort Study of the Tolerability of Prosthetic Joint Infection Empirical Antimicrobial Therapy. Antimicrob Agents Chemother 2018;62:e00163-18. [PMID: 30038037 DOI: 10.1128/AAC.00163-18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
39 Zasowski EJ, Murray KP, Trinh TD, Finch NA, Pogue JM, Mynatt RP, Rybak MJ. Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin. Antimicrob Agents Chemother 2018;62:e01684-17. [PMID: 29084753 DOI: 10.1128/AAC.01684-17] [Cited by in Crossref: 41] [Cited by in F6Publishing: 24] [Article Influence: 8.2] [Reference Citation Analysis]
40 Covert KL, Knoetze D, Cole M, Lewis P. Vancomycin plus piperacillin/tazobactam and acute kidney injury risk: A review of the literature. J Clin Pharm Ther 2020;45:1253-63. [PMID: 32810312 DOI: 10.1111/jcpt.13249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Saad MO, Mohamed AM, Mitwally HA, Shible AA, Ait Hssain A, Abdelaty MA. Evaluation of the risk of acute kidney injury with the use of piperacillin/tazobactam among adult critically ill patients. Infection 2020;48:741-7. [PMID: 32700095 DOI: 10.1007/s15010-020-01480-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Rungkitwattanakul D, Ives AL, Harriott NG, Pan-Chen S, Duong L. Comparative incidence of acute kidney injury in patients on vancomycin therapy in combination with cefepime, piperacillin-tazobactam or meropenem. J Chemother 2021;:1-7. [PMID: 34424136 DOI: 10.1080/1120009X.2021.1965334] [Reference Citation Analysis]
43 Abouelkheir M, Alsubaie S. Pediatric acute kidney injury induced by concomitant vancomycin and piperacillin-tazobactam. Pediatr Int 2018;60:136-41. [PMID: 29181890 DOI: 10.1111/ped.13463] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
44 An S, Luo H, Wang J, Gong Z, Tian Y, Liu X, Ma J, Jiang R. An acute kidney injury prediction nomogram based on neurosurgical intensive care unit profiles. Ann Transl Med 2020;8:194. [PMID: 32309341 DOI: 10.21037/atm.2020.01.60] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]